Private Enterprise in China: Tianda Pharmaceuticals “Anti-Epidemic Formula 1” granules approved to sell in Australia (Multi-sources)

08.05.2020

Tianda Pharmaceuticals（00455）announces its “Anti-Epidemic Formula 1” granules has been approved for entry into the Australian Register of Therapeutic Goods as a listed medicine. This will allow the Group to supply and sell Anti-Epidemic Formula 1 in Australia. The group indicates that the Anti-Epidemic Formula 1 is a preventive prescription mainly for improving people’s immune system, helping them to prevent influenza or COVID-19. Tianda Pharmaceuticals has made further plans for the product development of Anti-Epidemic Formula 1, Anti-Epidemic Formula 2 and Anti-Epidemic Formula 3 altogether to better serve the general public. The Group has opened two TCM clinics “TDMall” in Zhuhai and Hong Kong, and it will continuously seek development in the Guangdong-Hong Kong-Macau the Greater Bay Area.

Sources: ET Net, Hong Kong Economic Times

This is an English translation of the original Chinese text. If there is any inconsistency or ambiguity between the English version and the Chinese version, the Chinese version shall prevail.